Marksans Pharma Ltd

NSE : MARKSANS

BSE: 524404

SECTOR : PHARMACEUTICALS

No data to show from BSE

52w high/low	₹97.6 / ₹49.15
P/E ratio	91.64
Dividend	0.19
ROE	11.89
ROCE	14.82
Face value	1
Book value	₹28.49Cr
Market capital	₹14,077.53Cr

Shareholding pattern

What is shareholding pattern? Who are shareholders?

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders.

Promoters are typically the founders and public shareholders could be financial institutes like banks, insurance companies, domestic institutional investors, foreign institutional investors and common public.

Cash flow

What is a cash flow statement?

It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments.The main components of the CFS are cash from three areas: operating, investing, and financing activities...Read more

Balance Sheet

What is a balance sheet?

A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend.The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out:

Assets = Liabilities + Shareholder's Equity

This is used to conduct fundamental analysis or the estimation of financial ratios alongside other essential financial statements, such as income statement and statement of cash flows...Read more

Profit and loss

What is a profit and loss statement?

A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and management whether the company has incurred profits or losses and in which areas.

Key Ratios

PE TTM

91.64

P/B

10.91

ROE

11.89

ROCE

14.82

Dividend yield

0.19%

EPS TTM

3.39

EBTIDA Growth

32.57

D/E

0.01

Sector PE

47.31

₹28.49Cr

Peer Comparison

Dividends

What are dividends?

Dividend, in financial terms, means a certain amount shared with shareholders of a company or a mutual fund on a regular basis – monthly, quarterly or annually. Read more

Bonuses

What are bonuses?

A bonus issue is an offer given to the existing shareholders of the company to subscribe for additional shares. Instead of increasing the dividend payout, the companies off... Read more

Company News

Sorry, we do not have any data here.

Sector News

Sorry, we do not have any data here.

About Marksans Pharma Ltd

Marksans Pharma Limited is a public limited company incorporated in the year April 16th, 1982. The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation. The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. The Company on 30th March 2015, issued and allotted 240,06,494 equity shares of Rs1/- each to qualified institutional buyers under QIP for cash at Rs54. 67 (including premium) per Equity Share. In accordance to terms of issue, the Directors in their meeting held on 7th February, 2015 decided to redeem entire 13,50,000 7% Redeemable Cumulative Preference Shares of face value Rs100/- per share at par out of profits in tranches before due date of redemption i. e 27th March, 2018. Accordingly, on 7th February 2015, the Directors redeemed 1,00,000 preference shares at par.